Anastrozole CAS 120511-73-1 API Factory High Quality

Description:

Nomen: Anastrozole

CAS: 120511-73-1

Aspectus: Alba ad Off-White Crystalline pulveris

Intenta: 98.0%~ 102.0%

AnastrozoleCuratio Cancer

API High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Manufacturer Supple cum High puritate et stabulo Quality
Nomen chemicum: Anastrozole
CAS: 120511-73-1

Chemical Properties:

Nomen	Anastrozole
Synonyma	Arimidex;α, α, α', α'- Tetramethyl-5- (1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetonitrile
CAS Number	120511-73-1
CATTUS Number	RF-API74
Stock Status	In Stock, Productio Ascendite usque ad Centum chiliogrammata
Formulae hypotheticae	C17H19N5
M. Pondus	293.37
Solubilitas	Solutum in DMSO et Ethanol
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Alba ad Off-White Crystalline pulveris
Lepidium sativum	IR/MS Conform with reference vexillum
Lepidium sativum B *	HPLC et apicem figura: Responde referat
Liquescens punctum	81.0~84.0℃
Aqua Content (per KF)	≤0.30%
Residere in Ignition	≤0.10%
Damnum in Siccatio	≤0.50%
Metalla gravis	≤10ppm
Substantiae cognatae
immunditiam A	≤0.10%
impudicitia B	≤0.20%
immunditia C	≤0.20%
immunditia D	≤0.10%
immunditia E	≤0.10%
Una alia immunditia	≤0.10%
Totalis immunditias	≤0.50%
RELICTUM Solvents
Cyclohexane	≤0.30%
Ethyl Acetate	≤0.50%
Assay	98.0% ~ 102.0% (ex exaruit basis )
Fasciae vita	XXIV Menses
Test Standard	Enterprise Latin;Pharmacopoeia Civitatum Foederatarum (USP) Standard
Consuetudinem	Curatio Cancer

Sarcina & Repono:

sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.

commoda:

FAQ:

Applicatio:

Anastrozole (CAS 120511-73-1), est non-steroidale, triazolum achiralum tertium-generatio derivativa, sicut ARIMIDEX® venales per AstraZeneca Pharmaceutica LP1.Inhibitor aromatasi tertiae-generationis est unus, qui auctor est valde auctor et selectivus inhibitor aromatasi, et sic impedit conversionem testosteronis in estradiolum et androstenedionem in estrone.Inhibitio enzyme aromatasi praecipue fit per concursum aromatasi ad hemeglobum cytochromi P450 ligamen, estrogen biosynthesis decrescens in fibris periphericis corporis et in pectore.

Anastrozole fere curatio est bene tolerata pro carcinomate carcinomatis praematuro.Sicut alii inhibitores aromatasi, effectus eius gravissimus adversarius augebatur periculum fracturae ossis, quod anastrozolum restrictum fuit ad tempus curationis.Proprie habet toxicitatem mitem comparatam cum chemotherapy;tamen animadversum est plures aegros cum anastrozolo curatos esse, de symptomatibus iuncturam querentibus quam expectari, praesertim digitales rigorem similem cum arthritis rheumatoideis.Nonnullae probationes clinicae anastrozolae pro feminis postmenopausalibus in cancro pectori in Europa et in Civitates Americae Unitas nuntiaverunt perturbationes musculoskeletales tamquam eventus adversos.Anastrozole (Arimidex®) est inhibitor aromatasis probatus in EU, in US et in aliis regionibus terrarum ad usum adhibitis curationi in feminis postmenopausalibus cum praematuro, hormone receptori-positivo carcinomatis pectoris.Laudatur etiam in UE et aliis terrarum regionibus ad continuandam medicinam adjuvandam in mulieribus, quae iam 2-3 annos ad medicinam tamoxifen adjuvant pro carcinomate pectoris.